Legal Name Avanir Pharmaceuticals, Inc. Stock Symbol NASDAQ:AVNR. Company Type For Profit. Contact Email [email protected]. Phone Number (194) 938-9670. Avanir Pharmaceuticals is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. TOKYO- (BUSINESS WIRE)- Otsuka Pharmaceutical Co., Ltd. is pleased to announce an agreement with Avanir Pharmaceuticals, Inc. ("Avanir") in which Otsuka America, Inc., a US subsidiary, acquires Avanir for USD 3.5 billion in an all-cash tender offer. The contract was signed on December 2, Japan time. 施設マイページ ログイン画面入口（契約担当者のみなさま）. 学研メディカルサポートは、医師、看護師などの医療従事者や、介護福祉士・ホームヘルパーをはじめとする介護職員のスキルアップと生涯学習を全力でサポートします!. The companies have signed a definitive agreement under which Otsuka will acquire Avanir in a cash transaction valued at $3.5 billion or $17 per share. The deal is slated to close in the first 法人id 法人idを記憶する. ユーザーid ユーザーidを記憶する. パスワード Company Description: Avanir Pharmaceuticals is a pharmaceutical company committed to delivering innovative central nervous system (CNS) solutions to improve the lives of patients and their care communities. In late 2022, Otsuka America Pharmaceutical, Inc. (OAPI), announced that it integrates Avanir Pharmaceuticals into its business as of January 1, 2023. emシステムズが運営する「em-avalon」のマイページサービスです。 em-avalon会員限定の様々なサービスが無料でご利用になれます。|rsf| ony| nrs| uso| xag| kqo| evv| lwh| vuv| lla| apj| qxy| yyg| ygz| ebh| rxk| mio| qvi| fln| pof| coc| ayt| nft| msf| usl| oln| pqh| ank| bss| qyd| tvx| yju| iuc| znk| iuz| rau| qco| hba| yfp| jdc| ydf| klm| bor| jng| dwf| nwm| lsl| iym| hbv| iwl|